US: +1 512 898-9222
SG: +65 3138-4148
Medical Device Registration in Taiwan
Medical Devices are overseen by the Taiwan Food and Drug Administration (TFDA), a division of the Ministry of Health and Welfare. As of May 2021, the regulatory system will be governed by the new Medical Devices Act.
Medical Device Status
According to the Medical Devices Act, the term “medical devices” refer to instruments, machines, apparatus, materials, software, reagents for in vitro use, and related articles thereof, whose design and use achieve one of the following primary intended actions in or on the human body by other than pharmacological, immunological, metabolic, or chemical means:
- Diagnosis, treatment, alleviation, or direct prevention of human diseases.
- Modification or improvement of the structure and function of human body.
- Control of conception.
Taiwan Medical Device Registration Process
The first step to determining the regulatory pathway is to classify the product into one of the following four classifications:
- Class I (Low Risk)
- Class II (Medium Risk)
- Class III (High Risk)
- New (No predicate device previously approved by TFDA)
Class II, III, and New medical device applications will undergo two stages of review: Administrative and Technical. Class I products only require an Administrative Review.
Identifying a Predicate Device
Identifying a predicate device is a very important part of the Taiwan registration process. On May 21, 2021, the TFDA released an announcement outlining the “Determination Process of Similar Products of Medical Devices and Instructions for Application by Letter of Inquiry” which can be found here. Manufacturers seeking registration in Taiwan will need to identify a predicate device by working with a local partner, like Asia Actual, to find similar approved products or using the public database, found here, to find similar products.
Documents required as part of the application include:
- Application form
- Copies of Chinese labeling, instruction for use, packaging inserts.
- A copy of Pharmaceutical License for Medical Device Manufacturer/Distributor/Agent.
- Truth and Accuracy Statement.
- Free Sale Certificate issued by the health authority by the country of origin (for imported products) and authorization letter issued by manufacturer.
- Copies of preclinical test, quality control procedure and test reports.
- Copies of product structure, material, specifications, intended use and drawings.
- A copy of GMP/QSD Compliance Letter.
- Literature Review (Class III IVDs and New products only).
- Clinical Investigation Reports (Class III IVDs and New products only).
- Radioactive safety information (if applicable).
Clinical data is only required for Class III IVDs and New products. Class II medical devices with approval in the US or EU can usually use existing documentation in place of the preclinical test, quality control procedure and test reports.
Once issued, the License is valid for 5 years. Licenses in Taiwan are transferrable and will need to be completed by both the transferor and the transferee jointly.
Quality System Requirements
Before manufacturers can begin marketing their Class I Measuring/Sterile, Class II, or III products in Taiwan, they will need to provide evidence of a Quality System Documentation (QSD) in accordance with Taiwan’s Good Manufacturing Practices (GMP). This process can take up to up to 10 months to acquire and can be done alongside the application review. Approvals will not be issued before the QSD is approved. QSD is not required for Class I non-measuring, non-sterile products.
Expedited Quality System Review
Manufacturers can also leverage their ISO 13485 certificate if it was obtained by 1 of the 6 TCP III approved Notified Body. TCP III stands for the 3rd version of the TFDA-EU Technical Cooperation Program (TCP). To be eligible for this program, a Notified Body will need to be in compliance with (EU) 2017/745 and (EU) 2017/746.
The following documents are required when applying for transferring the right of the medical device permit license holder:
- Application form for change in medical device permit license
- Original copy of the medical device permit license
- Original copy of a permit letter of assignment from the pharmaceutical firm transferring agency rights (assignor)
- An affidavit from the pharmaceutical firm receiving agency rights (assignee) affirming responsible for the transferred medicament
- Original copy of the foreign original manufacturer’s authorization certificate; its content shall explain in detail about termination of the rights of the transferor, and bestowing of such rights to the transferee, and shall state the product name and the names and addresses of assignor and assignee, and the certificate shall be valid with one year from the date of issuance by the original manufacturer
- Affidavit (A)
- Photocopy of pharmaceutical firm license of the assignee
|Class I||Class I (Sterile/Measuring)||Class II||Class III||New (No Predicate)|
|TFDA Application Fee||NT$ 15,000|
|Application Timeline||1-2 Months||7-8 Months||8-12 Months||9-14 Months||10-15 Months|
|QSD Application Fee||N/A||NT$ 39,000|
|QSD Timeline||N/A||6 Months||6-8 Months||6-8 Months||6-8 Months|
GROW WITH US
Asia Actual is available to help navigate the medical device registration requirements and regulatory pathway for medical device and IVDs in Taiwan.
Contact Asia Actual for a free consultation discussing the potential for your medical device or IVD in the Taiwanese market.
Taiwan Regulatory Support
US: +1 512 898-9222
- India Grants Import License Grace Period for Class A/B DevicesSeptember 30, 2022 - 11:48 am
- India Issues Draft Notification for Exempting Certain Class A Medical DevicesSeptember 29, 2022 - 2:35 pm
- Transfer of Product Registration of Alcohol Swabs from CDRRHR to CDRRSeptember 14, 2022 - 1:26 pm
- Vietnam’s DMEC Provides Update on Issuance of C/D LicensesSeptember 14, 2022 - 11:42 am
- Philippines FDA Publishes Revised Draft of New IVD RegulationsSeptember 9, 2022 - 10:20 am